Remove Disease Remove Health IT Remove Nuclear Medicine
article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Thomas Hope, MD, a radiologist and nuclear medicine physician at the University of California, San Francisco (UCSF), said that approval of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand has driven a marked interest and excitement about theranostics and radioligand therapies (RLT). Hope added.

article thumbnail

7 ways to reduce healthcare disparities in radiology

AuntMinnie

Avoidable differences in disease burden and outcomes that socially disadvantaged individuals may experience manifest in nearly all areas of radiology, from emergency imaging, neuroradiology, and nuclear medicine to image-guided interventions and imaging-based cancer screening, the group noted.